Houston Rx LLC recalls Tirzepatide/Niacinamide 2mL vial (40 MG per Vial) Inj 20mg/2mg/mL
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- What's wrong
- Lack of assurance of sterility.
- Products
-
- Tirzepatide/Niacinamide 2mL vial (40 MG per Vial) Inj 20mg/2mg/mL
- Company
- Houston Rx LLC
- Where it was sold
-
Nationwide in the USA.
- Units affected
- 64 vials
- Status
- Ongoing
Recall Relay is not affiliated with or endorsed by FDA or any agency. Details here are copied from the FDA notice and may lag behind it; the official notice is always the final word.